To more clearly distinguish the phenotype of tumor-infiltrating dendritic cells (TIDCs), TIDCs were regarded as either mature dendritic cells by higher intensity CD11c+/lower intensity CD11b+, or tolerogenic dendritic cells by lower intensity CD11c+/higher intensity CD11b+. Here, ITGAX is linked to neoplasm.